1. Home
  2. CPK vs CGON Comparison

CPK vs CGON Comparison

Compare CPK & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPK
  • CGON
  • Stock Information
  • Founded
  • CPK 1990
  • CGON 2010
  • Country
  • CPK United States
  • CGON United States
  • Employees
  • CPK N/A
  • CGON N/A
  • Industry
  • CPK Oil & Gas Production
  • CGON
  • Sector
  • CPK Utilities
  • CGON
  • Exchange
  • CPK Nasdaq
  • CGON NYSE
  • Market Cap
  • CPK 2.8B
  • CGON 2.1B
  • IPO Year
  • CPK N/A
  • CGON 2024
  • Fundamental
  • Price
  • CPK $121.47
  • CGON $26.31
  • Analyst Decision
  • CPK Hold
  • CGON Strong Buy
  • Analyst Count
  • CPK 2
  • CGON 10
  • Target Price
  • CPK $126.50
  • CGON $64.44
  • AVG Volume (30 Days)
  • CPK 151.3K
  • CGON 837.2K
  • Earning Date
  • CPK 08-07-2025
  • CGON 08-07-2025
  • Dividend Yield
  • CPK 2.25%
  • CGON N/A
  • EPS Growth
  • CPK 9.39
  • CGON N/A
  • EPS
  • CPK 5.43
  • CGON N/A
  • Revenue
  • CPK $840,200,000.00
  • CGON $662,000.00
  • Revenue This Year
  • CPK $13.95
  • CGON N/A
  • Revenue Next Year
  • CPK $3.52
  • CGON $25,206.93
  • P/E Ratio
  • CPK $22.46
  • CGON N/A
  • Revenue Growth
  • CPK 20.34
  • CGON 224.51
  • 52 Week Low
  • CPK $104.56
  • CGON $14.80
  • 52 Week High
  • CPK $136.73
  • CGON $40.47
  • Technical
  • Relative Strength Index (RSI)
  • CPK 49.18
  • CGON 51.15
  • Support Level
  • CPK $118.98
  • CGON $25.51
  • Resistance Level
  • CPK $122.11
  • CGON $26.54
  • Average True Range (ATR)
  • CPK 2.44
  • CGON 1.09
  • MACD
  • CPK 0.31
  • CGON -0.09
  • Stochastic Oscillator
  • CPK 55.04
  • CGON 33.56

About CPK Chesapeake Utilities Corporation

Chesapeake Utilities Corp is a diversified energy delivery company that is engaged in natural gas transmission and distribution, electricity generation and distribution, propane gas distribution, mobile compressed natural gas utility services and solutions and other businesses. The company operates in two reportable segments, Regulated Energy and Unregulated Energy. The company's natural gas and electric distribution operations in Delaware, Maryland and Florida are subject to regulation by PSC. Eastern Shore, its natural gas transmission is subject to regulation by the FERC and Peninsula Pipeline and Aspire Energy Express, its intrastate pipeline subsidiaries, are subject to regulation by the Florida PSC and Public Utilities Commission of Ohio, respectively.

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

Share on Social Networks: